Pilot Study of Percutaneous Correction of Hallux Valgus
Recruiting
N/A
Interventional Study
Hallux Valgus
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 40 (estimated)
- Sponsor
- Istituto Ortopedico Rizzoli · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a pilot study with a randomized controlled design.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients of both sexes with adult hallux valgus with indication for corrective surgical treatment
* HVA (hallux valgus angle): 20°-40°
* IMA (intermetatarsal angle): 10°-20°
Exclusion Criteria:
* Patients with instability of the first metatarsophalangeal joint
* Patients wit…
Contacts